IN‐VITRO SUSCEPTIBILITY OF E. COLI, SHIGELLAE AND SALMONELLAE TO KANAMYCIN AND THERAPEUTIC IMPLICATIONS*
- 1 June 1966
- journal article
- abstracts
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 132 (2) , 1006-1012
- https://doi.org/10.1111/j.1749-6632.1966.tb43025.x
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- KANAMYCIN IN ANTHRAX, TYPHOID, PARATYPHOID, AND BRUCELLOSISAnnals of the New York Academy of Sciences, 2006
- KANAMYCIN: EXPERIENCE IN SELECTED CASESAnnals of the New York Academy of Sciences, 2006
- In Vitro Susceptibility of Shigellae to Sodium Sulfadiazine and to Eight AntibioticsJAMA, 1965
- Coliform Septicemia Complicating Shigellosis in ChildrenJAMA, 1965
- KanamycinArchives of internal medicine (1960), 1959
- Susceptibility and Cross-Resistance of Bacteria to Four Related Antibiotics: Kanamycin, Paromomycin, Neomycin and StreptomycinExperimental Biology and Medicine, 1958
- SOME EXPERIENCES WITH KANAMYCIN IN THE TREATMENT OF SALMONELLA AND SHIGELLA INFECTIONSAnnals of the New York Academy of Sciences, 1958
- CLINICAL EVALUATION OF THE NEW ANTIBIOTIC: KANAMYCIN*Annals of the New York Academy of Sciences, 1958
- KANAMYCIN FOR BOWEL STERILIZATION*Annals of the New York Academy of Sciences, 1958
- Studies of the Acute Diarrheal Diseases: X C. Further Cultural Observations on the Relative Efficacy of Sulfonamides in Shigella InfectionsPublic Health Reports®, 1945